Michael Feld, executive vice president and chief revenue officer at Becton Dickinson & Co. (BDX), sold 76 company shares on Sept. 28, 2026, according to an SEC insider-filing report published Sept. 30. The supplied summary lists a price of $183.70 per share and a transaction value of $13,961.

The report identifies the transaction as a sale under a scheduled 10b5-1 plan. That designation provides context for the reported trade, but the brief summary does not provide the plan’s terms or its adoption date.

Transaction details and reporting date

The SEC source identifies the disclosure as a Form 4 reporting entry for Feld. The supplied publication timestamp is Sept. 30, 2026, at 01:13:54 UTC, two calendar days after the transaction date. That timestamp identifies when the supplied report was published; the summary does not separately give the filing’s acceptance time.

Multiplying the reported 76 shares by the stated $183.70 price produces $13,961.20. The $13,961 amount in the summary is consistent with rounding that calculation to the nearest dollar. It represents the reported sale value, not an established measure of Feld’s profit or proceeds after any costs or taxes.

What the disclosure establishes

The available information identifies the seller, his corporate role, the company and ticker, the number of shares sold, the transaction date, the stated price and the scheduled-plan designation.

It does not state Feld’s remaining holdings, the proportion of his ownership represented by this sale or his acquisition cost. It also provides no statement from Feld explaining the transaction.

Analysis: The scheduled-plan label is relevant when interpreting the sale. This summary alone cannot establish Feld’s current view of Becton Dickinson’s prospects or support a conclusion about the company’s operating performance.

What to watch

The full filing would be the next document to examine for any ownership balances, transaction footnotes or additional plan details. Those particulars are absent from the supplied summary, limiting conclusions beyond the reported sale.